A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/120, 167/261
A61K 31/28 (2006.01) A61K 31/195 (2006.01) A61K 31/30 (2006.01)
Patent
CA 1188219
Rheumatoid arthritis is treated with substituted cysteine compounds having a lower toxicity-to-effectiveness ratio than penicillamine. Such compounds are specific alpha-substituted cysteines, beta-monosubstituted cysteines, beta-di-substituted cysteines other than penicillamine, N-acetyl penicillamine and the N-acetyl derivatives of the alpha and beta-substituted com- pounds mentioned above. Any of the compounds may be used synergistically in combination with suitable copper compounds or with suitable gold compounds in the treatment of arthritis. The same compounds are effective in the treatment of cystinuria and heavy metal poisoning. The same compounds as well as penicillamine are effective in combination with copper in the treatment of heavy metal poisoning.
395752
Borden Ladner Gervais Llp
Schein Pharmaceutical Inc.
LandOfFree
Method of treatment of rheumatoid arthritis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treatment of rheumatoid arthritis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treatment of rheumatoid arthritis will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1334479